The table below shows ABBOTT LABORATORIES's income statement by quarter, as reported in the company's quarterly filings. All figures are in US dollars; negative values appear in red.
Line item
Q1 2026
Q3 2025
Q2 2025
Q1 2025
Q3 2024
Q2 2024
Revenue
$11.16B
$11.37B
$11.14B
$10.36B
$10.63B
$10.38B
Cost of revenue
$4.89B
$5.08B
$4.85B
$4.47B
$4.70B
$4.60B
Gross profit
-
-
-
-
-
-
R&D
$767.00M
$766.00M
$725.00M
$716.00M
$713.00M
$698.00M
ABT annual revenue (10-K history)
ABBOTT LABORATORIES reported annual revenue of $44.33B for fiscal year 2025. That is up 5.7% from $41.95B in fiscal 2024. Over the 10 fiscal years shown, annual revenue grew from $20.85B (FY 2016) to $44.33B. Figures come from the company's audited annual reports as filed with the SEC.
